Evidence map›Paper›PMID 39494903›Full record

ArticleJournal of virology2024

Rapid production of recombinant rotaviruses by overexpression of NSP2 and NSP5 genes with modified nucleotide sequences.

Yuta Kanai, Tomohiro Kotaki, Satoko Sakai, Toshie Ishisaka, Kayoko Matsuo, Yukino Yoshida, Katsuhisa Hirai, Shohei Minami, Takeshi Kobayashi

Abstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuta KanaiDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-5102-6951
Tomohiro KotakiDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Satoko SakaiDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Toshie IshisakaDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Kayoko MatsuoKumamoto Prefectural Aso Livestock Hygiene Service Center, Aso, Japan.
Yukino YoshidaDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Katsuhisa HiraiDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Shohei MinamiDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-3999-348X
Takeshi KobayashiDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-5532-207X

Funding

Japan Agency for Medical Research and Development (AMED) JP21fk0108122,JP21lm0203014,JP22gm1610008,JP23gm0108668,JP223fa627002MEXT | Japan Society for the Promotion of Science (JSPS) JP21H02739,JP21K19379,JP18K19444MEXT | Japan Society for the Promotion of Science (JSPS) JP22H03117,JP18K07145,JP16K19138MEXT | JST | Moonshot Research and Development Program (Moonshot) JPMJMS2025
6 · The paper itself

Abstract

Reverse genetics systems for rotaviruses (RV) facilitate the generation of genetically engineered RVs by transfection of 11 plasmids encoding 11 genomic viral RNA segments. In addition to viral genome expression, overexpression of NSP2 and NSP5 has been used to increase the rescue efficiency of recombinant RVs. Here, we showed that the overexpression of nucleotide sequence-modified NSP2 and NSP5 enabled the rapid and efficient production of recombinant RVs. Using improved reverse genetics, we established a reverse genetics system for human and bovine RV clinical isolates, as well as laboratory strains of bovine RV (NCDV and UK) and porcine RV (Gottfried). In addition, we rescued low-replicating recombinant RVs carrying a mutant NSP4 lacking the double-layered particle-binding domain, which was deficient in the efficient production of mature virions. These advancements in reverse genetics enabled the generation of molecular clones of RV clinical isolates and recombinant RVs harboring critical amino acid mutations, offering a versatile platform for investigating RV biology and pathogenesis.IMPORTANCERecombinant rotavirus (RV) synthesis via reverse genetics relies on both the viral propagation capacity and the efficiency of the experimental system. Since the establishment of our reverse genetics system, several enhancements have been implemented to augment the rescue efficiency. Nevertheless, challenges persist in generating RV clinical strains and recombinant viruses with low replication capacities. Notably, this improved reverse genetics system successfully facilitated the establishment of molecular clones of human and bovine RV clinical isolates. Fecal samples from patients with RV typically harbor quasi-species or, occasionally, multiple genotypes of RV. In the present study, we performed the genetic sequencing of clinical viral strains during the early propagation stages in cultured cells. Subsequently, infectious viruses were synthesized, allowing the characterization of circulating viruses in nature. This approach provides valuable insights into the genetic diversity and dynamics of RV populations and contributes to a more comprehensive understanding of viral pathogenesis and evolution.

Indexed as

Reverse GeneticsRotavirusViral Nonstructural ProteinsVirus ReplicationAnimalsBase SequenceCattleCell LineGenome, ViralGlycoproteinsHumansRNA-Binding ProteinsRNA-Dependent RNA PolymeraseRNA, ViralRotavirus InfectionsSwineGlycoproteinsNS35 protein, rotavirusNSP5 protein, rotavirus group ARNA-Binding ProteinsRNA-Dependent RNA PolymeraseRNA, ViralToxins, BiologicalViral Nonstructural Proteinsreverse genetics analysisrotavirus

Identifiers

PMID39494903
PMCPMC11650980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.